Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
HLTH
PRCD
SOBIV
Swedish Orphan Biovitrum AB (publ)kr2,500
2EMEA
Nov 12, 2024
currency
SEK
size (m)
1,150.000
maturity
Nov 19, 2026
type
Floating
tenor
2.000
call
-
registration
-
benchmark
3mSt
ranking
Sr. Unsecured
moody's
-
s&p
-
fitch
-
size description
-
re-open/tap
No
ipt
-
ipt-pxd
-
guidance
-
spread
90
coupon
3mSt+90
spread set
-
price
100.00000
yield
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
-
active leads
-
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
-
active leads
-
joint leads
passive leads
-
co-managers
-
coordinating managers
-
currency
SEK
size (m)
1,350.000
maturity
Feb 19, 2030
type
Floating
tenor
5.250
call
-
registration
-
benchmark
3mSt
ranking
Sr. Unsecured
moody's
-
s&p
-
fitch
-
size description
-
re-open/tap
No
ipt
-
ipt-pxd
-
guidance
-
spread
160
coupon
3mS+160
spread set
-
price
100.00000
yield
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
-
active leads
-
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
-
active leads
-
joint leads
passive leads
-
co-managers
-
coordinating managers
-
Tranche Comments
2 yr: Comments: SEK1.15bn 2yr FRNs snr unsec. NR. HCM/Danske. Final 2yr 3mS+90 at par. Par Call: 1m. LEI: 549300124Y3MQI87PT35; 5.25 yr: Comments: SEK1.35bn 5.25yr FRNs snr unsec. NR. HCM/Danske. Final 5.25yr 3mS+160 at par. Par Call: 3m. LEI: 549300124Y3MQI87PT35;
Use of Proceeds
General Corporate Purposes

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.